MoonLake Immunotherapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
04 Oct 24 | SellUS$100,003,200 | BVF Partners L.P. | Company | 2,000,000 | US$50.00 | |
04 Oct 24 | SellUS$9,186,120 | Simon Sturge | Individual | 171,000 | US$53.72 |
Insider Trading Volume
Insider Buying: MLTX insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 8,892,241 | 12.7% |
Hedge Funds | 28,185,846 | 40.3% |
Institutions | 32,868,303 | 47% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
19,691,695 | US$1.1b | -9.47% | 30.92% | |||
8,494,151 | US$460.1m | 0% | 21.67% | |||
4,948,050 | US$268.0m | 35.9% | 0.02% | |||
2,988,650 | US$161.9m | 0% | no data | |||
2,980,249 | US$161.4m | 16.4% | 0.01% | |||
2,973,390 | US$161.1m | 0% | no data | |||
2,770,100 | US$150.1m | 0% | 2.02% | |||
2,322,971 | US$125.8m | 2.53% | 0.13% | |||
2,051,961 | US$111.2m | 0% | no data | |||
1,585,167 | US$85.9m | -2.53% | 0.33% | |||
1,476,749 | US$80.0m | 19.9% | 0.04% | |||
1,167,358 | US$63.2m | 4.45% | 0.26% | |||
1,154,385 | US$62.5m | 5.07% | 0.09% | |||
1,130,328 | US$61.2m | 0.17% | 0.14% | |||
998,140 | US$54.1m | -2.31% | 0.02% | |||
931,480 | US$50.5m | 0% | 1.74% | |||
666,574 | US$36.1m | 1.14% | 0.16% | |||
646,662 | US$35.0m | 0% | 0.5% | |||
603,335 | US$32.7m | 0% | 1.94% | |||
580,789 | US$31.5m | 11.3% | 0.01% | |||
529,657 | US$28.7m | 0% | no data | |||
505,000 | US$27.4m | -72.3% | 0.05% | |||
500,000 | US$27.1m | -26.3% | 0.1% | |||
441,000 | US$23.9m | 24.2% | 0.97% | |||
409,203 | US$22.2m | 603% | 0.02% |